Literature DB >> 12648181

Decreased serum leptin levels in women with uterine leiomyomas.

Te-Fu Chan1, Jinu-Huang Su, Yueh-Fang Chung, Hsueh-Ling Chang, Shyng-Shiou F Yuan.   

Abstract

OBJECTIVE: To analyze the possible involvement of leptin in uterine leiomyomas. STUDY
DESIGN: Serum leptin levels, determined by radioimmunoassay, were compared in myomatic (n = 50) and the normal (n = 50) women.
RESULTS: A significant correlation was found between serum leptin levels and body mass index in both the myomatic women (r = 0.76, p < 0.001) and the normal women (r = 0.56, p < 0.001). Serum leptin levels in the myomatic women (9.3 +/- 0.6 ng/mL) were significantly lower (p < 0.001) than those in the normal women (13.6 +/- 1.2 ng/mL). In addition, the ratios of serum leptin levels/body mass index in the myomatic women (0.38 +/- 0.02) were significantly lower than those in the normal women (0.57 +/- 0.04) (p < 0.001). A significant correlation was found between the ratios of serum leptin levels/body mass index and body mass index (r = 0.59, p < 0.001) in the normal women, but not in the myomatic women (r = 0.27, p = 0.061).
CONCLUSION: The lower plasma leptin levels observed in the women with myomas were independent of body mass index, and unlike the normal women there was no significant up-regulation of leptin production in response to increased adiposity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648181     DOI: 10.1034/j.1600-0412.2003.00026.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Potential role of leptin expression in hepatocellular carcinoma.

Authors:  S-N Wang; Y-T Yeh; S-F Yang; C-Y Chai; K-T Lee
Journal:  J Clin Pathol       Date:  2006-03-24       Impact factor: 3.411

2.  Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Qing Lu; Yan-Rong Lu; Jie Zhang; Yan Liu; Wen-Dong Wang
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.